Showing codes J7665 (Mannitol, administered through an inhaler, 5 mg) — J8565 (Gefitinib, oral, 250 mg)

J7665 - Mannitol for inhaler
Long description: Mannitol, administered through an inhaler, 5 mg
Code added date: 20120101.
Code effective date: 20130101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7667 - Metaproterenol comp con
Long description: Metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligrams
Code added date: 20070101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7668 - Metaproterenol non-comp con
Long description: Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 10 milligrams
Code added date: 20000101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7669 - Metaproterenol non-comp unit
Long description: Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
Code added date: 20000101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7670 - Metaproterenol comp unit
Long description: Metaproterenol sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
Code added date: 20070101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7674 - Methacholine chloride, neb
Long description: Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg
Code added date: 20050101.
Code effective date: 20050101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7676 - Pentamidine comp unit dose
Long description: Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg
Code added date: 20080101.
Code effective date: 20080101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7677 - Revefenacin inh non-com 1mcg
Long description: Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram
Code added date: 20190701.
Code effective date: 20190701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7680 - Terbutaline sulf comp con
Long description: Terbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
Code added date: 20000101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7681 - Terbutaline sulf comp unit
Long description: Terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
Code added date: 20000101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7682 - Tobramycin non-comp unit
Long description: Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams
Code added date: 20000101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7683 - Triamcinolone comp con
Long description: Triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
Code added date: 20000101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7684 - Triamcinolone comp unit
Long description: Triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
Code added date: 20000101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7685 - Tobramycin comp unit
Long description: Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams
Code added date: 20070101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7686 - Treprostinil, non-comp unit
Long description: Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg
Code added date: 20110101.
Code effective date: 20110101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7699 - Inhalation solution for dme
Long description: Noc drugs, inhalation solution administered through dme
Code added date: 19930101.
Code effective date: 20070101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7799 - Non-inhalation drug for dme
Long description: Noc drugs, other than inhalation drugs, administered through dme
Code added date: 19930101.
Code effective date: 20020701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7999 - Compounded drug, noc
Long description: Compounded drug, not otherwise classified
Code added date: 20160101.
Code effective date: 20160101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J8498 - Antiemetic rectal/supp nos
Long description: Antiemetic drug, rectal/suppository, not otherwise specified
Code added date: 20060101.
Code effective date: 20060101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J8499 - Oral prescrip drug non chemo
Long description: Prescription drug, oral, non chemotherapeutic, nos
Code added date: 19950101.
Code effective date: 19970101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: M (A code denoting Medicare coverage status).
HTML    PDF

J8501 - Oral aprepitant
Long description: Aprepitant, oral, 5 mg
Code added date: 20050101.
Code effective date: 20190101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J8510 - Oral busulfan
Long description: Busulfan; oral, 2 mg
Code added date: 20000101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J8515 - Cabergoline, oral 0.25mg
Long description: Cabergoline, oral, 0.25 mg
Code added date: 20060101.
Code effective date: 20060101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: M (A code denoting Medicare coverage status).
HTML    PDF

J8520 - Capecitabine, oral, 150 mg
Long description: Capecitabine, oral, 150 mg
Code added date: 20000101.
Code effective date: 20160101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J8521 - Capecitabine, oral, 500 mg
Long description: Capecitabine, oral, 500 mg
Code added date: 20000101.
Code effective date: 20160101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J8530 - Cyclophosphamide oral 25 mg
Long description: Cyclophosphamide; oral, 25 mg
Code added date: 19950101.
Code effective date: 19970831.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J8540 - Oral dexamethasone
Long description: Dexamethasone, oral, 0.25 mg
Code added date: 20060101.
Code effective date: 20060101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J8560 - Etoposide oral 50 mg
Long description: Etoposide; oral, 50 mg
Code added date: 19950101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J8561 - Oral everolimus
Long description: Everolimus, oral, 0.25 mg
Code added date: 20120101.
Code effective date: 20130101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J8562 - Oral fludarabine phosphate
Long description: Fludarabine phosphate, oral, 10 mg
Code added date: 20110101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J8565 - Gefitinib oral
Long description: Gefitinib, oral, 250 mg
Code added date: 20050101.
Code effective date: 20150101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF